JBS N.V.
NYSE:JBSPackaged Foods
-$0.34 today
- Market cap
- $26.66B
- Beta
- 0.17
- P/E (TTM)
- 6.9
- EPS (TTM)
- $8.91
- Dividend yield
- 8.41%
Volume 9.80M
Average 6.65M
JBS Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
JBS N.V.NYSE: JBS
Depreciation & Amortization · Q3 FY2026 · quarter ended Sep 2026
Depreciation & amortization dips below year-ago levels
Q3 FY2026 depreciation & amortization of $3.45B fell 24.3% year over year, behind the +0.0% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 6.7% from the prior quarter. Over 3 fiscal years it compounded at +7.9% a year.
Context
- Depreciation & amortization amounted to 2.7% of revenue in FY2025, down 0.2 pp from a year earlier.
- Depreciation & amortization increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -24.3% toward the trailing-twelve-month pace of +0.0%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
BRL · from the cash flow
- Latest · FY2025
- 12.63B BRL
- Year-over-year change
- +5.6%
- 4-year CAGR
- +8.7%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 12.63B | +5.6% |
| FY2024 | 2024-12-31 | 11.95B | +15.2% |
| FY2023 | 2023-12-31 | 10.38B | +3.2% |
| FY2022 | 2022-12-31 | 10.05B | +11.4% |
| FY2021 | 2021-12-31 | 9.03B | — |
Depreciation & Amortization vs competitors
How JBS compares with its peers on the latest reported figures
- Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +0.0% is the 5th highest of 6, against a peer median of +2.7%.
- Depreciation & amortization amounts to 3.8% of revenue for JBS, versus a peer median of 2.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
JBSJBS N.V. | LTM Jun 2026 | R$14.43B BRL | +0.0% | +7.9% | 3.8% |
| LTM Oct 2026 | $1.4B USD | +2.7% | +1.4% | 2.5% | |
| LTM Jun 2026 | $479.92M USD | +9.0% | +4.2% | 2.6% | |
| LTM Sep 2026 | $339M USD | +1.5% | -9.0% | 2.2% | |
| LTM Oct 2026 | $330M USD | -0.6% | +10.6% | 3.1% | |
| LTM Jul 2026 | $271.72M USD | +4.1% | +0.1% | 2.2% | |
| Peer median (excluding JBS) | — | +2.7% | +1.4% | 2.5% | |
Competitors are the stored peer set for JBS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 20.49B | 15.46B | (1.06B) | 9.62B | 11.1B |
| Depreciation & Amortization | 9.03B | 10.05B | 10.38B | 11.95B | 12.63B |
| Deferred Income Tax | 0 | 0 | 0 | 0 | (361.42M) |
| Stock-Based Compensation | 63.43M | 39.13M | 34.42M | 85.6M | 0 |
| Change in Working Capital | (20.84B) | (8.85B) | 3.41B | (7.34B) | (11.86B) |
| Accounts Receivables | (4.27B) | (1.3B) | 3.13B | (2.02B) | (1.45B) |
| Inventory | (11.79B) | (6.78B) | (300.66M) | (4.73B) | (4.58B) |
| Accounts Payables | 0 | 0 | 0 | 0 | 3.01B |
| Other Working Capital | (4.78B) | (774.46M) | 580.45M | (592.03M) | (8.85B) |
| Other Non-Cash Items | 12.74B | (3.36B) | (1.26B) | 9.24B | 3.99B |
| Operating Cash Flow | 21.48B | 13.33B | 11.5B | 23.56B | 15.49B |
| Capital Expenditures | (9.62B) | (11.23B) | (7.49B) | (8.08B) | (11.37B) |
| Acquisitions (Net) | (9.34B) | (1.98B) | (17.16M) | (31.46M) | 394.77M |
| Purchases of Investments | 0 | 0 | 0 | 0 | (1.26B) |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 102.65M | 81.04M | 485.19M | 382.02M | (285.38M) |
| Investing Cash Flow | (18.86B) | (13.12B) | (7.02B) | (7.73B) | (12.56B) |
| Debt Repayment | 17.73B | 264.72M | 7.45B | (1.65B) | 7.15B |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (10.6B) | (3.65B) | 0 | (44.49M) | (3.19B) |
| Dividends Paid | (7.4B) | (4.44B) | (2.22B) | (4.44B) | (8.81B) |
| Other Financing Activities | (575.4M) | (939.51M) | (218.37M) | (1.16B) | (5.12B) |
| Financing Cash Flow | (844.5M) | (8.76B) | 5.01B | (7.3B) | (9.97B) |
| Effect of Forex Changes | 1.78B | (1.51B) | (545.05M) | 4.11B | 1.32B |
| Net Change in Cash | 3.56B | (10.06B) | 8.94B | 12.64B | (5.71B) |
| Free Cash Flow | 11.86B | 2.11B | 4.01B | 15.47B | 4.13B |
JBS N.V.
NYSE:JBS
Intrinsic Alpha fair value
Locked
Current Price
$12.02
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.